£107.98

Springer Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Price data last checked 33 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 58 days • 58 data points (No recent data available)

Historical
Generating forecast...
£107.98 £107.38 £107.51 £107.64 £107.77 £107.90 £108.04 05 April 2026 19 April 2026 03 May 2026 17 May 2026 01 June 2026

Price Distribution

Price distribution over 58 days • 2 price levels

Days at Price
Current Price
23 days 35 days · current 0 9 18 26 35 £107 £108 Days at Price

Price Analysis

Most common price: £108 (35 days, 60.3%)

Price range: £107 - £108

Price levels: 2 different prices over 58 days

Description

Multiple myeloma remains incurable, immune to developments in cancer treatment such as high-dose chemotherapy and new kinds of agents. This volume assesses new approaches currently being developed that overcome drug resistance and improve patient outcomes. From the Back Cover Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients.   This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 December 2014
Listed Since
04 December 2014

Barcode

No barcode data available

Similar Products You Might Like

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research
90% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research

Springer

£107.98 31 May 2026
Multiple Myeloma: Diagnosis and Treatment
87% match

Multiple Myeloma: Diagnosis and Treatment

Springer

£74.05 06 Jun 2026
Multiple Myeloma - a New Era of Treatment Strategies
85% match

Multiple Myeloma - a New Era of Treatment Strategies

£85.29 08 Jun 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
83% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Advances in Cancer Stem Cell Biology
83% match

Advances in Cancer Stem Cell Biology

Springer

£107.98 01 Jun 2026
Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)
83% match

Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)

Springer

£110.24 25 May 2026
Bone Metastases: A translational and Clinical Approach: 21 (Cancer Metastasis - Biology and Treatment, 21)
82% match

Bone Metastases: A translational and Clinical Approach: 21 (Cancer Metastasis - Biology and Treatment, 21)

Springer

£108.92 24 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
82% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
82% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 01 Jun 2026
The Biology of Skeletal Metastases: 118 (Cancer Treatment and Research, 118)
82% match

The Biology of Skeletal Metastases: 118 (Cancer Treatment and Research, 118)

Springer

£108.61 18 May 2026
Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)
82% match

Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)

Springer

£77.39 04 Jun 2026
Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)
81% match

Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)

Springer

£86.87 03 Jun 2026
Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
81% match

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Springer

£113.77 17 May 2026
Molecular Basis for Therapy of AIDS-Defining Cancers
81% match

Molecular Basis for Therapy of AIDS-Defining Cancers

Springer

£107.98 24 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
81% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Molecular Targets and Strategies in Cancer Prevention
81% match

Molecular Targets and Strategies in Cancer Prevention

Springer

£107.33 25 May 2026
Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)
81% match

Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)

Springer

£81.58 06 Jun 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
81% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
81% match

Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia

£60.00 12 Jun 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
80% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.98 29 May 2026
Cell Adhesion and Cytoskeletal Molecules in Metastasis: 9 (Cancer Metastasis - Biology and Treatment, 9)
80% match

Cell Adhesion and Cytoskeletal Molecules in Metastasis: 9 (Cancer Metastasis - Biology and Treatment, 9)

Springer

£100.97 05 Jun 2026
Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies (Advances in Blood Disorders, 2)
80% match

Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies (Advances in Blood Disorders, 2)

Routledge

£87.05 25 May 2026
DNA Repair of Cancer Stem Cells
80% match

DNA Repair of Cancer Stem Cells

Springer

£107.98 19 May 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
80% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£142.27 04 Jun 2026